Gene Therapy for Rare Disorders

March 30, 2020 – April 2, 2020  • Boston, MA

Visit the Event Page

Gene Therapy for Rare Disorders focuses exclusively on overcoming the late-stage commercial challenges drug developers face when delivering gene therapies to market. Incorporating insights from Spark, FDA, Bluebird Bio, Pfizer and GSK, this unique conference delves into the key regulatory, reimbursement, clinical and manufacturing hurdles that need to be overcome to realize the commercial potential of gene therapies.